Omnicare Clinical Research Opens New Office in South Korea
King of Prussia, PA
Omnicare Clinical Research announced that it has opened an office in Seoul, Korea.
“Since 2006, we have been conducting studies in South Korea with a local partner,” said Benoit Martin, President, International for Omnicare Clinical Research. “Opening our own office in Seoul enables us to strengthen our presence in the Asia Pacific Region, as well as reinforce our global commitment to our clients. The new facility will also create added value in response to the Japanese Authorities’ mandate to provide data outside of Japan.”
Omnicare Clinical Research has had a presence in the Asia Pacific Region since its Australia office opened in 1985. The company has other offices in the area including: Beijing and Shanghai, China; Singapore; Taipei, Taiwan; Tokyo, Japan; and Bangalore, India.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
